Bacteriophages are bacterial viruses that infect the host after successful receptor recognition
and adsorption to the cell surface. The irreversible adherence followed by genome material …

The emergence of bacteria resistance to most of the currently available antibiotics has
become a critical therapeutic problem. The bacteria causing both hospital and community …

Antibiotics have the remarkable power to control bacterial infections. Unfortunately,
widespread use, whether regarded as prudent or not, has favored the emergence and …

The increasing prevalence of infections caused by multidrug-resistant Klebsiella
pneumoniae necessitates the development of alternative therapies. Here, we isolated …

Currently, the bacterial resistance, especially to most commonly used antibiotics has proved
to be a severe therapeutic problem. Nosocomial and community-acquired infections are …

Biofilm formation is one of the main causes of increased antibiotic resistance in
Acinetobacter baumannii infections. Bacteriophages and their derivatives, such as tail …

As of 29 July 2022, there had been a cumulative 572,239,451 confirmed cases of COVID-19
worldwide, including 6,390,401 fatalities. COVID-19 patients with severe symptoms are …

Bacteriophage therapy dates back almost a century, but the discovery of antibiotics led to a
rapid decline in the interests and investments within this field of research. Recently, the …

Escherichia coli is one of the most notorious pathogens for its ability to adapt, colonize, and
proliferate in different habitats through a multitude of acquired virulence factors. Its presence …

Enzyme-based therapeutics (EBTs) have the potential to tap into an almost unmeasurable
amount of enzyme biodiversity and treat myriad conditions. Although EBTs were some of the …